222 related articles for article (PubMed ID: 32017476)
1. Assessment of visfatin concentrations in the serum of male psoriatic patients in relation to metabolic abnormalities.
Chyl-Surdacka KM; Bartosińska J; Kowal M; Przepiórka-Kosińska J; Krasowska D; Chodorowska G
Adv Clin Exp Med; 2020 Jan; 29(1):79-84. PubMed ID: 32017476
[TBL] [Abstract][Full Text] [Related]
2. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
[TBL] [Abstract][Full Text] [Related]
3. Serum Visfatin, Adiponectin, and Tumor Necrosis Factor Alpha (TNF-α) Levels in Patients with Psoriasis and their Correlation with Disease Severity.
Sereflican B; Goksugur N; Bugdayci G; Polat M; Haydar Parlak A
Acta Dermatovenerol Croat; 2016 Apr; 24(1):13-9. PubMed ID: 27149125
[TBL] [Abstract][Full Text] [Related]
4. Correlation of metabolic syndrome with serum omentin-1 and visfatin levels and disease severity in psoriasis and psoriatic arthritis.
Dağdelen D; Karadag AS; Kasapoğlu E; Wang JV; Erman H
Dermatol Ther; 2020 Nov; 33(6):e14378. PubMed ID: 33029930
[TBL] [Abstract][Full Text] [Related]
5. Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.
Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
J Clin Lab Anal; 2016 Jul; 30(4):284-9. PubMed ID: 25867925
[TBL] [Abstract][Full Text] [Related]
6. Analysis of serum chemerin concentrations in psoriatic patients in relation to metabolic abnormalities.
Chyl-Surdacka KM; Gerkowicz A; Bartosińska J; Kowal M; Przepiórka-Kosińska J; Surdacki G; Krasowska D; Chodorowska G
Postepy Dermatol Alergol; 2019 Oct; 36(5):531-537. PubMed ID: 31839769
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the chosen parameters of metabolic status in patients with psoriasis].
Kacalak-Rzepka A; Kiedrowicz M; Maleszka R
Ann Acad Med Stetin; 2013; 59(2):12-7. PubMed ID: 25026745
[TBL] [Abstract][Full Text] [Related]
8. Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome.
Barrea L; Macchia PE; Di Somma C; Napolitano M; Balato A; Falco A; Savanelli MC; Balato N; Colao A; Savastano S
J Transl Med; 2016 May; 14(1):130. PubMed ID: 27165166
[TBL] [Abstract][Full Text] [Related]
9. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis".
Caso F; Postiglione L; Covelli B; Ricciardone M; Di Spigna G; Formisano P; D'Esposito V; Girolimetto N; Tasso M; Peluso R; Navarini L; Ciccozzi M; Margiotta DPE; Oliviero F; Afeltra A; Punzi L; Del Puente A; Scarpa R; Costa L
Clin Rheumatol; 2019 Sep; 38(9):2547-2552. PubMed ID: 31147798
[TBL] [Abstract][Full Text] [Related]
10. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
11. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
12. Circulating visfatin levels in healthy preterm infants are independently associated with high-density lipoprotein cholesterol levels and dietary long-chain polyunsaturated fatty acids.
Siahanidou T; Margeli A; Kappis A; Papassotiriou I; Mandyla H
Metabolism; 2011 Mar; 60(3):389-93. PubMed ID: 20359723
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity.
Ismail SA; Mohamed SA
Br J Dermatol; 2012 Aug; 167(2):436-9. PubMed ID: 22486212
[TBL] [Abstract][Full Text] [Related]
14. Elevated visfatin levels in obese children are related to proinflammatory factors.
Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
[TBL] [Abstract][Full Text] [Related]
15. Leptin, adiponectin, visfatin and retinol-binding protein-4 - mediators of comorbidities in patients with psoriasis?
Gerdes S; Osadtschy S; Rostami-Yazdi M; Buhles N; Weichenthal M; Mrowietz U
Exp Dermatol; 2012 Jan; 21(1):43-7. PubMed ID: 22151390
[TBL] [Abstract][Full Text] [Related]
16. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity.
Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M
Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858
[TBL] [Abstract][Full Text] [Related]
18. Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney disease.
Mu J; Feng B; Ye Z; Yuan F; Zeng W; Luo Z; Qi W
J Nephrol; 2011; 24(2):177-84. PubMed ID: 20602330
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile.
Filippatos TD; Tsimihodimos V; Derdemezis CS; Gazi IF; Saougos V; Mikhailidis DP; Tselepis AD; Elisaf MS
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):330-6. PubMed ID: 21963513
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin, visfatin and regional fat depots in normal weight obese premenopausal women.
Miazgowski T; Safranow K; Krzyżanowska-Świniarska B; Iskierska K; Widecka K
Eur J Clin Invest; 2013 Aug; 43(8):783-90. PubMed ID: 23650969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
